PharmChem, Inc. (PCHM)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 391.93 Thousand USD | 143.68% |
| 2022 | 160.84 Thousand USD | 136.5% |
| 2021 | 68 Thousand USD | -9.54% |
| 2020 | 75.18 Thousand USD | 15.1% |
| 2019 | 65.32 Thousand USD | -44.78% |
| 2018 | 118.29 Thousand USD | 36.65% |
| 2017 | 86.57 Thousand USD | -9.14% |
| 2016 | 95.28 Thousand USD | 0.0% |
| 2002 | 1.31 Million USD | -42.8% |
| 2001 | 2.3 Million USD | 24.2% |
| 2000 | 1.85 Million USD | -4.08% |
| 1999 | 1.93 Million USD | 26.82% |
| 1998 | 1.52 Million USD | -5.22% |
| 1997 | 1.6 Million USD | 58.68% |
| 1996 | 1.01 Million USD | -40.35% |
| 1995 | 1.7 Million USD | 0.0% |
| 1994 | 1.7 Million USD | 6.25% |
| 1993 | 1.6 Million USD | 23.08% |
| 1992 | 1.3 Million USD | 30.0% |
| 1991 | 1 Million USD | 11.11% |
| 1990 | 900 Thousand USD | 80.0% |
| 1989 | 500 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 250.74 Thousand USD | -36.02% |
| 2024 Q2 | 175.92 Thousand USD | -29.84% |
| 2023 FY | 391.93 Thousand USD | 143.68% |
| 2023 Q1 | 125.86 Thousand USD | -21.75% |
| 2023 Q2 | 283.38 Thousand USD | 125.15% |
| 2023 Q3 | 294.54 Thousand USD | 3.94% |
| 2023 Q4 | 391.93 Thousand USD | 33.07% |
| 2022 FY | 160.84 Thousand USD | 136.5% |
| 2022 Q2 | 319.73 Thousand USD | 33.71% |
| 2022 Q4 | 160.84 Thousand USD | -32.73% |
| 2022 Q1 | 239.12 Thousand USD | 251.6% |
| 2022 Q3 | 239.1 Thousand USD | -25.22% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q4 | 68 Thousand USD | 37.37% |
| 2021 FY | 68 Thousand USD | -9.54% |
| 2021 Q3 | 49.5 Thousand USD | 0.0% |
| 2020 FY | 75.18 Thousand USD | 15.1% |
| 2019 FY | 65.32 Thousand USD | -44.78% |
| 2018 FY | 118.29 Thousand USD | 36.65% |
| 2017 FY | 86.57 Thousand USD | -9.14% |
| 2016 FY | 95.28 Thousand USD | 0.0% |
| 2003 Q1 | 1.15 Million USD | -12.59% |
| 2003 Q2 | 1.05 Million USD | -8.42% |
| 2003 Q3 | 975 Thousand USD | -7.58% |
| 2002 Q4 | 1.31 Million USD | 0.53% |
| 2002 Q1 | 1.84 Million USD | -20.1% |
| 2002 FY | 1.31 Million USD | -42.8% |
| 2002 Q2 | 1.6 Million USD | -12.82% |
| 2002 Q3 | 1.31 Million USD | -18.32% |
| 2001 FY | 2.3 Million USD | 24.2% |
| 2001 Q2 | 1.68 Million USD | -10.07% |
| 2001 Q3 | 2.65 Million USD | 57.32% |
| 2001 Q4 | 2.3 Million USD | -13.19% |
| 2001 Q1 | 1.87 Million USD | 1.13% |
| 2000 Q2 | 1.78 Million USD | -5.01% |
| 2000 Q4 | 1.85 Million USD | 6.85% |
| 2000 FY | 1.85 Million USD | -4.08% |
| 2000 Q1 | 1.87 Million USD | -2.95% |
| 2000 Q3 | 1.73 Million USD | -2.64% |
| 1999 Q3 | 1.7 Million USD | 13.33% |
| 1999 FY | 1.93 Million USD | 26.82% |
| 1999 Q4 | 1.93 Million USD | 13.76% |
| 1999 Q2 | 1.5 Million USD | 0.0% |
| 1999 Q1 | 1.5 Million USD | -1.64% |
| 1998 Q4 | 1.52 Million USD | -10.29% |
| 1998 FY | 1.52 Million USD | -5.22% |
| 1998 Q3 | 1.7 Million USD | 6.25% |
| 1998 Q2 | 1.6 Million USD | 6.67% |
| 1998 Q1 | 1.5 Million USD | -6.77% |
| 1997 Q3 | 1.4 Million USD | -22.22% |
| 1997 Q1 | 900 Thousand USD | -11.24% |
| 1997 FY | 1.6 Million USD | 58.68% |
| 1997 Q2 | 1.8 Million USD | 100.0% |
| 1997 Q4 | 1.6 Million USD | 14.93% |
| 1996 FY | 1.01 Million USD | -40.35% |
| 1996 Q2 | 1.3 Million USD | -23.53% |
| 1996 Q4 | 1.01 Million USD | -7.82% |
| 1996 Q3 | 1.1 Million USD | -15.38% |
| 1996 Q1 | 1.7 Million USD | 0.0% |
| 1995 FY | 1.7 Million USD | 0.0% |
| 1995 Q4 | 1.7 Million USD | 6.25% |
| 1995 Q1 | 1.4 Million USD | -17.65% |
| 1995 Q3 | 1.6 Million USD | 0.0% |
| 1994 Q4 | 1.7 Million USD | -10.53% |
| 1994 Q3 | 1.9 Million USD | 0.0% |
| 1994 Q1 | 1.9 Million USD | 18.75% |
| 1994 FY | 1.7 Million USD | 6.25% |
| 1993 FY | 1.6 Million USD | 23.08% |
| 1993 Q2 | 1.6 Million USD | 0.0% |
| 1993 Q3 | 1.5 Million USD | -6.25% |
| 1993 Q4 | 1.6 Million USD | 6.67% |
| 1992 Q4 | 1.3 Million USD | 0.0% |
| 1992 FY | 1.3 Million USD | 30.0% |
| 1991 FY | 1 Million USD | 11.11% |
| 1991 Q4 | 1 Million USD | 0.0% |
| 1990 Q4 | 900 Thousand USD | 0.0% |
| 1990 FY | 900 Thousand USD | 80.0% |
| 1989 FY | 500 Thousand USD | 0.0% |
| 1989 Q4 | 500 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -3.413% |
| Arrayit Corporation | 464.19 Thousand USD | 15.566% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 48.225% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 16533.417% |
| DermTech, Inc. | 1 Million USD | 60.962% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 88.12% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 56.898% |
| iMD Companies, Inc. | 38.31 Thousand USD | -922.907% |
| IDenta Corp. | 442.28 Thousand USD | 11.383% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 68.057% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -140.253% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 50.008% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 104616.533% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 16.391% |
| Proteome Sciences plc | 1.06 Million USD | 63.216% |
| Response Genetics, Inc | 133 Thousand USD | -194.689% |
| Rennova Health, Inc. | 242.64 Thousand USD | -61.527% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -430.383% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -309.886% |
| Todos Medical Ltd. | 1.02 Million USD | 61.612% |